How to Inject Semaglutide This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like ...

Results from the Phase 3b STEP UP trial showed that a higher dose of semaglutide (7.2 mg) delivered 21%* weight loss in people with obesity with a third of participants losing 25% or more of their ...

Medically reviewed by Danielle Weiss, MD Zepbound (tirzepatide) and Wegovy (semaglutide) are drugs approved by the Food and Drug Administration (FDA) to treat type 2 diabetes as well as obesity and ...

Under brand names like Wegovy and Ozempic, semaglutide assists weight loss and manages diabetes through a series of weekly injections. Unfortunately, the small sting that's required with every dose ...

TUESDAY, Sept. 16, 2025 (HealthDay News) — A triple-sized weekly dose of Ozempic works better to help people with obesity shed excess pounds without significant side effects, new clinical trial ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with or without type 2 diabetes, a pair of phase IIIa trials found. This ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you’re pregnant or hoping to become pregnant, it’s ...

Low doses of the injectable weight-loss medication semaglutide may improve symptoms of a hard-to-treat type of heart failure. This effect happened through direct action on the heart muscle and blood ...

GLP-1 receptor agonists, of which semaglutide (a.k.a. Ozempic) is the most well known example, has revolutionized obesity ...

Please provide your email address to receive an email when new articles are posted on . Adults receiving nimacimab plus semaglutide had a 2.95 percentage point greater weight loss than semaglutide ...

A ‘triple-strength’ weight-loss jab has just been approved by NHS watchdog Medicines and Healthcare products Regulatory ...